We are live on ! Find out more
BCDA icon

BioCardia
BCDA

24 hedge funds and large institutions have $1.37M invested in BioCardia in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13,600% more call options, than puts

Call options by funds: $137K | Put options by funds: $1K

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

92% more capital invested

Capital invested by funds: $710K → $1.37M (+$656K)

50% more funds holding

Funds holding: 16 → 24 (+8)

0.12% more ownership

Funds ownership: 0.51% → 0.63% (+0.12%)

Holders
24
Holders Change
+8
Holders Change %
+50%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
1
Closed
–
Calls
$137K
Puts
$1K
Net Calls
+$136K
Net Calls Change
+$26K

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$54.1K
2
Renaissance Technologies
Renaissance Technologies
New York
+$42.1K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$35.4K
4
VF
Virtu Financial
New York
+$22.4K
5
Citadel Advisors
Citadel Advisors
Florida
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$49
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
1
CM Management
Florida
$465K +$54.1K +6,667 +17%
Vanguard Group
2
Vanguard Group
Pennsylvania
$432K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$106K +$7.84K +966 +10%
Renaissance Technologies
4
Renaissance Technologies
New York
$59K +$42.1K +5,187 +741%
FM
5
Family Management
New York
$51.5K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$43.5K +$35.4K +4,362 New
BlackRock
7
BlackRock
New York
$28.4K +$5.97K +736 +35%
VF
8
Virtu Financial
New York
$27K +$22.4K +2,757 New
Citadel Advisors
9
Citadel Advisors
Florida
$22.3K +$18.2K +2,242 New
Brown Advisory
10
Brown Advisory
Maryland
$22K – – –
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$17K +$8.6K +1,060 +158%
SRL
12
Scientech Research LLC
New Jersey
$14.9K +$12.5K +1,535 New
Osaic Holdings
13
Osaic Holdings
Arizona
$14.2K – – –
State Street
14
State Street
Massachusetts
$13.9K – – –
Northern Trust
15
Northern Trust
Illinois
$12.8K – – –
HF
16
HRT Financial
New York
$12K +$4.24K +522 +75%
WS
17
Wedbush Securities
California
$10K – – –
PP
18
Pingora Partners
Wyoming
$4.93K +$4.01K +494 New
Bank of America
19
Bank of America
North Carolina
$4.34K +$8 +1 +0.2%
GRP
20
Global Retirement Partners
California
$3.83K +$3.34K +412 New
Morgan Stanley
21
Morgan Stanley
New York
$598 -$49 -6 -9%
TRCT
22
Tower Research Capital (TRC)
New York
$159 +$130 +16 New
Wells Fargo
23
Wells Fargo
California
$65 +$8 +1 +17%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
– +$122 +15 New

BCDA Hedge Fund Activity: Q4 2023 in Review

24 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2023, worth a combined $1.37M — up 92% from $710K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BCDA positions and 0 closed out — a net gain of 8 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was CM Management, adding an estimated $54.1K. The largest seller was Morgan Stanley, cutting an estimated $49.

  • 24 institutional investors held BioCardia (BCDA) as of Q4 2023, up from 16 in Q3 2023.
  • Funds reported $1.37M of BioCardia stock for Q4 2023, up 92% quarter-over-quarter.
  • 8 funds opened new BioCardia positions in Q4 2023 and 0 closed out, a net change of +8 holders.
  • The largest BioCardia buyer in Q4 2023 was CM Management, an estimated $54.1K added.
  • The largest BioCardia seller in Q4 2023 was Morgan Stanley, an estimated $49 sold.

Based on aggregated 13F filings for Q4 2023.